Patent Expiry

Patent/Exclusivity Expiry: AVMAPKI FAKZYNJA CO-PACK (COPACKAGED)

Other upcoming events for VSTM

Phase 3 ReadoutPhase 3 Topline: A Phase 3, Randomized, Open-Label Study of Combination Therapy With Avutometinib Plus Defactinib Ver

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: AVMAPKI FAKZYNJA CO-PACK (COPACKAGED) — VSTM Patent Expiry | BioSniper